Ironwood Pharmaceuticals Inc (IRWD)
6.475
-0.16
(-2.48%)
USD |
NASDAQ |
May 17, 16:00
6.475
0.00 (0.00%)
After-Hours: 20:00
Ironwood Pharmaceuticals Gross Profit (TTM)
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| December 31, 2020 | 386.39M |
| September 30, 2020 | 385.89M |
| June 30, 2020 | 413.08M |
| March 31, 2020 | 414.56M |
| December 31, 2019 | 404.54M |
| September 30, 2019 | 398.48M |
| June 30, 2019 | 328.89M |
| March 31, 2019 | 315.03M |
| December 31, 2018 | 313.89M |
| September 30, 2018 | 289.88M |
| June 30, 2018 | 309.56M |
| March 31, 2018 | 294.09M |
| December 31, 2017 | 279.18M |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | 109.91M |
| Date | Value |
|---|---|
| March 31, 2015 | 78.49M |
| December 31, 2014 | 62.25M |
| September 30, 2014 | 30.42M |
| June 30, 2014 | 16.41M |
| March 31, 2014 | 26.34M |
| December 31, 2013 | 15.68M |
| September 30, 2013 | 37.20M |
| June 30, 2013 | 130.70M |
| March 31, 2013 | 139.06M |
| December 31, 2012 | 149.28M |
| September 30, 2012 | 155.42M |
| June 30, 2012 | 71.22M |
| March 31, 2012 | 67.88M |
| December 31, 2011 | 65.87M |
| September 30, 2011 | 50.49M |
| June 30, 2011 | 47.33M |
| March 31, 2011 | 45.26M |
| December 31, 2010 | 43.86M |
| September 30, 2010 | 35.49M |
| June 30, 2010 | 41.69M |
| March 31, 2010 | 39.11M |
| December 31, 2009 | 35.50M |
| September 30, 2009 | 32.07M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
328.89M
Minimum
Jun 2019
414.56M
Maximum
Mar 2020
390.26M
Average
398.48M
Median
Sep 2019
Gross Profit (TTM) Benchmarks
| Societal CDMO Inc (DELISTED) | 18.14M |
| Amicus Therapeutics Inc | 379.54M |
| Insmed Inc | 246.29M |
| Altimmune Inc | -- |
| InfuSystems Holdings Inc | 64.04M |